Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
CVS to Remove AbbVie’s Humira from Reimbursement Lists, Cover Biosimilars
BioSpace
Thu, 01/4/24 - 10:18 am
CVS Caremark
CVS Health
AbbVie
Humira
biosimilars
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
AbbVie
Immunogen
M&A
antibody-drug conjugate
AbbVie lawsuit says rival Adcentrx stole anti-cancer secrets
Reuters
Wed, 12/20/23 - 06:39 pm
legal
AbbVie
Adcentrx
trade secrets
US consumer group seeks stronger warnings on Botox, similar treatments
Reuters
Tue, 12/12/23 - 10:02 am
Public Citizen
FDA
Botox
AbbVie
Revance Therapeutics
Daxxify
Evolus
Jeuveau
Supernus Pharmaceuticals
Myobloc
Galderma
Dysport
AbbVie and Genmab report data from follicular lymphoma antibody trial
Clinical Trials Arena
Mon, 12/11/23 - 09:59 am
AbbVie
Genman
clinical trials
epcoritamab
bispecific antibodies
relapsed or refractory follicular lymphoma
FTC warns pharma companies on excessive drug patenting
Medical Marketing and Media
Fri, 12/8/23 - 10:05 am
FTC
AbbVie
AstraZeneca
Teva Pharmaceutical
patents
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy: 'This acquisition is not anti-competitive.'
Fierce Biotech
Thu, 12/7/23 - 11:08 pm
AbbVie
Cerevel Therapeutics
M&A
Richard Gonzalez
FTC
anticompetitive practices
AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
Wed, 12/6/23 - 09:23 pm
AbbVie
Cerevel Therapeutics
M&A
Neuroscience
Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Forbes
Mon, 12/4/23 - 10:14 am
Humira
AbbVie
biosimilars
FDA
J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey
Fierce Pharma
Sun, 12/3/23 - 09:36 pm
JNJ
AbbVie
Sanofi
Turkey
competition
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
Fri, 12/1/23 - 11:23 am
AbbVie
Teliso-V
antibody-drug conjugate
non-small cell lung cancer
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Medical Marketing and Media
Fri, 12/1/23 - 09:43 am
biotech stocks
AbbVie
Immunogen
M&A
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
AbbVie cues up filing for c-Met ADC in lung cancer
Pharmaphorum
Wed, 11/29/23 - 12:00 pm
AbbVie
Teliso-V
clinical trials
lung cancer
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
AbbVie
Rinvoq
patents
legal
Sandoz
Sun Pharma
Intas Pharmaceuticals
AbbVie’s Migraine Drug Ubrelvy Scores Victory in Phase III Study
BioSpace
Fri, 11/17/23 - 10:00 am
AbbVie
Ubrelvy
ubrogepant
migraines
clinical trials
Skyrizi goes sky-high in October among Rx, OTC pharma brands
Medical Marketing and Media
Sun, 11/12/23 - 09:19 pm
Boehringer Ingelheim
AbbVie
Skyrizi
DTC advertising
pharma advertising
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
Dermatology Times
Wed, 11/8/23 - 09:55 pm
Samsung Bioepis
Organon
FDA
AbbVie
Humira
biosimilars
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
Tue, 11/7/23 - 11:08 pm
FTC
Orange Book
patents
AbbVie
AstraZeneca
Boehringer Ingelheim
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
AbbVie
Daiichi Sankyo
Merck
antibody-drug conjugate
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »